Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals is a late-stage biopharma company developing treatments for retinal diseases. It has raised $150M, most recently in a Series B round in June 2023, and employs 56 people.
The growth story
Alkeus Pharmaceuticals, Inc. grew from 7 to 56 employees between 2021 and 2026, raising $150M along the way, most recently a Series B in June 2023.
About
Alkeus Pharmaceuticals develops therapies for retinal diseases, aiming to preserve vision in affected patients. Its late-stage pipeline suggests it is nearing commercialization.
The company has raised $150M, including a Series B in 2023 led by Bain Capital Life Sciences and others. With 56 employees, it operates in Cambridge, Massachusetts, a hub for biotech innovation.
Founders and leadership
Operations is the largest function at Alkeus, with 9 employees. The company has a median tenure of 1 year, indicating relatively recent hires dominate its workforce.
The Alkeus Pharmaceuticals, Inc. org chart
Michel Dahan (President and Chief Executive Officer) leads 40 mapped leaders with 8 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 11 (-21% YoY), Business Development 10 (+11% YoY), Healthcare Services 5 (+67% YoY), Program and Project Management 5 (+67% YoY), Customer Success and Support 4 (+33% YoY), Quality Assurance 4 (-20% YoY).
Talent flow
Alkeus recruits heavily from major biopharma firms, including Genentech, Apellis Pharmaceuticals, and Sanofi, each contributing 3 hires. Alumni often move to Dyne Therapeutics, which has hired 5 former Alkeus employees.
Most common previous employers of Alkeus Pharmaceuticals, Inc. staff: Genentech (3), Apellis Pharmaceuticals (3), Sanofi (3), Syros Pharmaceuticals (3), Sarepta Therapeutics (2), Boston Scientific (2). Former Alkeus Pharmaceuticals, Inc. employees most often moved to Dyne Therapeutics (5), PharmatrophiX (2), Biogen (2), Broad Spectrum GXP (1), Denali Therapeutics (1), Merck (1).
Alumni worth knowing
The Alkeus Pharmaceuticals, Inc. mafia
Alkeus alumni have founded 3 companies, including PharmatrophiX, Arborpointe Partners, and Anaka Pharmaceuticals. PharmatrophiX alone has 4 former Alkeus staff members.
3David Setboun, Pharm.D., MBA, was Chief Operating Officer until 2025Hampus Hillerstrom, was Co-founder and advisor until 2012Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Alkeus Pharmaceuticals, Inc.: Pharmaceutics (20), Clinical Trials (19), Biotechnology (18), Drug Development (17), Leadership (17), Project Management (16), Cross-functional Team Leadership (15), Team Leadership (14).
Where the team actually sits
Alkeus Pharmaceuticals, Inc. people are concentrated in Massachusetts, United States (17), Greater Boston (10), United States (4), Greater Chicago Area (2).
Search footprint
Alkeus Pharmaceuticals, Inc. attracts about 158 organic search visits a month, traffic worth roughly $2K a month if bought through ads. It gained 56 ranking keywords and lost 9 in the last period.
Frequently asked
Alkeus Pharmaceuticals, Inc. has 56 employees as of September 2026.
Alkeus Pharmaceuticals, Inc. has raised $150M in total, most recently a Series B round in June 2023.
Alkeus Pharmaceuticals, Inc. was founded in 2010 by ilyas washington.
Michel Dahan (President and Chief Executive Officer) sits at the top of Alkeus Pharmaceuticals, Inc.'s reporting structure, with 8 direct reports.
The most common previous employers of current Alkeus Pharmaceuticals, Inc. staff are Genentech (3 people), Apellis Pharmaceuticals (3 people), Sanofi (3 people).
Former Alkeus Pharmaceuticals, Inc. employees most often move to Dyne Therapeutics (5), PharmatrophiX (2), Biogen (2).
At least 3 companies have a founder who previously worked at Alkeus Pharmaceuticals, Inc., including PharmatrophiX, Arborpointe Partners, Anaka Pharmaceuticals.
Alkeus Pharmaceuticals, Inc. attracts about 158 organic search visits a month, worth roughly $2K a month in equivalent ad spend.
The most common skills among Alkeus Pharmaceuticals, Inc. staff are Pharmaceutics, Clinical Trials, Biotechnology, Drug Development, Leadership.
Alkeus Pharmaceuticals, Inc. staff are concentrated in Massachusetts, United States (17), Greater Boston (10), United States (4).
Alkeus Pharmaceuticals, Inc. has about 11 people in Research, down 21% over the past year, as of September 2026.
Alkeus Pharmaceuticals, Inc. has about 10 people in Business Development, up 11% over the past year, as of September 2026.
Computed from 46 current and 69 former Alkeus Pharmaceuticals, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.